In particular, in a study of Wahid et al. [29], performed on a limited number of patients (37 patients on sofosbuvir and 26 IFN-α treated patients), was reported high prevalence of hypothyroidism in both groups, with 18.9% observed in sofosbuvir group. Here, IFNA17 is linked to hypothyroidism.